Transcenta Holding Ltd 2023 SR
The report highlights Transcenta's progress in 2023 as a clinical-stage biopharmaceutical company, focusing on its 13 therapeutic antibody molecules. Key achievements include advancing several new molecular drugs to clinical stages, such as Osemitamab (TST001) for gastric cancer. The company strengthened its ESG governance by integrating climate risks into its risk management system and achieving ISO 14001 and ISO 45001 certifications for its Hangzhou plant. Social initiatives included the "Warm Winter Campaign" for community support and a 100% employee training coverage rate. Environmentally, the company implemented the Transcenta Operation Savings Scheme (TOSS) to reduce its carbon footprint and optimized wastewater treatment in its animal facilities.
Company: Transcenta Holding Ltd
Sector: Health Care
Country: China
Year: 2023
Type: SR
Pages: 79
Transcenta Holding Ltd
ESG Report
The report highlights Transcenta's progress in 2023 as a clinical-stage biopharmaceutical company, focusing on its 13 therapeutic antibody molecules. Key achievements include advancing several new molecular drugs to clinical stages, such as Osemitamab (TST001) for gastric cancer. The company strengthened its ESG governance by integrating climate risks into its risk management system and achieving ISO 14001 and ISO 45001 certifications for its Hangzhou plant. Social initiatives included the "Warm Winter Campaign" for community support and a 100% employee training coverage rate. Environmentally, the company implemented the Transcenta Operation Savings Scheme (TOSS) to reduce its carbon footprint and optimized wastewater treatment in its animal facilities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Published
Mar 27, 2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees